Maze Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 4.57 M | $136.33 M | 0.00% | 10.63% |
| TRV GP IV, LLC | 05/07/2026 | 4.47 M | $133.55 M | 0.00% | 10.41% |
| ARCH VENTURE MANAGEMENT, LLC | 05/15/2026 | 4.12 M | $122.98 M | 0.00% | 9.59% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 3.48 M | $103.81 M | -18.11% | 8.09% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 2.86 M | $85.28 M | -9.03% | 6.65% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 2.74 M | $81.92 M | 100.00% | 6.39% |
| BLACKROCK, INC. | 05/13/2026 | 2.57 M | $76.73 M | 12.39% | 5.98% |
| AH CAPITAL MANAGEMENT, L.L.C. | 05/15/2026 | 1.70 M | $50.81 M | 0.00% | 3.96% |
| VR ADVISER, LLC | 05/15/2026 | 1.60 M | $47.82 M | 3.45% | 3.73% |
| 05/15/2026 | 1.44 M | $42.85 M | 100.00% | 3.34% | |
| ALPHABET INC. | 05/08/2026 | 1.39 M | $41.45 M | 0.00% | 3.23% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 1.24 M | $36.86 M | 30.00% | 2.87% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 1.18 M | $35.16 M | 100.00% | 2.74% |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 05/15/2026 | 1.04 M | $30.92 M | 0.00% | 2.41% |
| TRV GP V, LLC | 05/07/2026 | 950.80 K | $28.38 M | 0.00% | 2.21% |
| FMR LLC | 05/15/2026 | 864.21 K | $25.80 M | 18.61% | 2.01% |
| CITADEL ADVISORS LLC | 05/15/2026 | 775.71 K | $23.16 M | 73.07% | 1.81% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2026 | 767.38 K | $22.91 M | 0.00% | 1.79% |
| CASDIN CAPITAL, LLC | 05/15/2026 | 758.86 K | $22.65 M | 0.00% | 1.77% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 750.00 K | $22.39 M | 100.00% | 1.75% |
| WOODLINE PARTNERS LP | 05/15/2026 | 650.23 K | $19.41 M | -37.19% | 1.51% |
| STATE STREET CORP | 05/15/2026 | 636.72 K | $19.01 M | 19.46% | 1.48% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2026 | 636.16 K | $18.99 M | 68.29% | 1.48% |
| CALIGAN PARTNERS LP | 05/15/2026 | 614.96 K | $18.36 M | 11.77% | 1.43% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 599.97 K | $17.91 M | 13.79% | 1.40% |
| BESSEMER GROUP INC | 05/06/2026 | 481.79 K | $14.38 M | 0.00% | 1.12% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 461.15 K | $13.77 M | 131.49% | 1.07% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 379.00 K | $11.31 M | -41.21% | 0.88% |
| FARALLON CAPITAL MANAGEMENT LLC | 05/15/2026 | 373.00 K | $11.13 M | 100.00% | 0.87% |
| HHLR ADVISORS, LTD. | 05/15/2026 | 366.03 K | $10.93 M | -20.00% | 0.85% |
| MARSHALL WACE, LLP | 05/15/2026 | 310.64 K | $9.27 M | -63.35% | 0.72% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 284.48 K | $8.49 M | -30.51% | 0.66% |
| WASHINGTON UNIVERSITY | 05/06/2026 | 280.80 K | $8.38 M | 0.00% | 0.65% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 279.71 K | $8.35 M | 144.39% | 0.65% |
| CANDRIAM S.C.A. | 04/30/2026 | 278.17 K | $8.30 M | 100.00% | 0.65% |
| 05/15/2026 | 257.50 K | $7.69 M | -47.45% | 0.60% | |
| MASS GENERAL BRIGHAM, INC | 05/05/2026 | 239.99 K | $7.16 M | 0.00% | 0.56% |
| FREESTONE GROVE PARTNERS LP | 05/15/2026 | 234.95 K | $7.01 M | 97.65% | 0.55% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 227.34 K | $6.79 M | 216.44% | 0.53% |
| ABRDN PLC | 04/29/2026 | 226.23 K | $6.75 M | 100.00% | 0.53% |
| NORTHERN TRUST CORP | 05/14/2026 | 211.38 K | $6.31 M | 19.93% | 0.49% |
| MORGAN STANLEY | 05/15/2026 | 204.83 K | $6.11 M | -20.63% | 0.48% |
| 05/14/2026 | 200.00 K | $5.97 M | 100.00% | 0.47% | |
| 05/08/2026 | 195.54 K | $5.84 M | 100.00% | 0.46% | |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 195.08 K | $5.82 M | 961.34% | 0.45% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 186.43 K | $5.57 M | 5.95% | 0.43% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 185.79 K | $5.55 M | 0.00% | 0.43% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 05/15/2026 | 156.90 K | $4.68 M | -69.98% | 0.37% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 151.00 K | $4.51 M | 100.00% | 0.35% |
| HOLOCENE ADVISORS, LP | 05/15/2026 | 136.17 K | $4.06 M | 100.00% | 0.32% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Maze Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 181 institutional investors and hedge funds held shares of Maze Therapeutics Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 4.57 M
TRV GP IV, LLC: 4.47 M
ARCH Venture Management, LLC: 4.12 M
Deep Track Capital, LP: 3.48 M
JANUS HENDERSON GROUP PLC: 2.86 M
Paradigm Biocapital Advisors LP: 2.74 M
120.25% of Maze Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 51.31 M shares in the last 24 months. This purchase volume represents approximately $2.31 B in transactions.